MétaCan
Menu
Retour à la cohorte
Enregistrement W2010038774 · doi:10.1097/00000539-200001000-00009

Cardiovascular Instability Requiring Treatment after Intravenous Heparin for Cardiopulmonary Bypass

2000· article· en· W2010038774 sur OpenAlex
Michael J. Jacka, Andrew G. Clark

Pourquoi ce travail est dans la base

Une base qui oublie comment elle a trouvé un travail ne peut pas être vérifiée. Voici les voies qui ont admis celui-ci.

affAu moins un auteur déclare une institution canadienne dans l'instantané OpenAlex épinglé.

Notice bibliographique

RevueAnesthesia & Analgesia · 2000
Typearticle
Langueen
DomaineMedicine
ThématiquePotassium and Related Disorders
Établissements canadiensSaint John Regional HospitalDalhousie University
Organismes subventionnairesnon disponible
Mots-clésMedicineActivated clotting timeAnesthesiaCardiopulmonary bypassHeparinHematocritHyperkalemiaBlood pressurePopulationBradycardiaCardiac surgeryHeart rateSurgeryInternal medicine

Résumé

récupéré en direct d'OpenAlex

We have observed hypotension (mean arterial pressure [MAP] < 60 mm Hg) and/or bradycardia (heart rate [HR] < 40 bpm) shortly after IV heparin loading for cardiopulmonary bypass (CPB) in several patients undergoing cardiac surgery. Serum electrolytes after these episodes of cardiovascular instability (CVI, defined as MAP < 60 mm Hg and/or HR < 40 bpm) often showed relative hyperkalemia. Hyperkalemia has been reported with chronic heparin administration (1–6), but only after several days of treatment, and has not been reported to occur acutely. The purposes of this report were to review the characteristics of the cases of CVI and to compare the cases of CVI with a control group. Methods Records of all patients undergoing cardiac surgery requiring CPB during a 6-mo period were reviewed to identify all episodes of CVI occurring within 10 min of IV heparin loading. Two hundred fifty-six patient records were reviewed. CVI occurred in 16 patients. The remaining 240 patients were considered the control population. All patients had blood analyzed in a similar fashion intraoperatively. The first sample was obtained from the arterial catheter, immediately after the anesthetic induction, for measurement of pH, PCO2, and hematocrit, as well as serum potassium (K+), sodium (Na+), and calcium levels. Porcine heparin (400 IU/kg) was administered to achieve an activated clotting time of ≥400 s. Another blood sample was obtained 5 min after the heparin bolus was administered. Analysis was performed on all blood using the same equipment, which was calibrated daily. Data recorded included patients’ age, weight, ejection fraction, serum creatinine, sex, history (and type) of diabetes, and history of use of angiotensin-converting-enzyme inhibitors, calcium channel blockers, beta-blockers, and any preoperative heparin infusion. Mean HR and MAP immediately preheparin and at the time of blood sampling were recorded. Statistical analysis was performed on continuous data using the paired or unpaired Student’s t-test as appropriate, with the Bonferroni correction applied as necessary. Categorical data were compared using the χ2 or Fisher’s exact test. Results CVI occurred in 16 of the 256 patients (6.25%). In the 16 patients with CVI, MAP decreased from 73.6 ± 14.3 mm Hg preheparin bolus to 56.7 ± 7.4 mm Hg postbolus, as mean HR decreased from 70.6 ± 9.3 bpm to 56.7 ± 12.1 bpm. Because the CVI was always treated, it is unknown if it would have continued or if spontaneous recovery might have occurred. All episodes of hypotension were initially treated with 5-mg increments of ephedrine IV. Thirteen patients had restoration of MAP to 60 mm Hg after 10 mg of ephedrine. Three patients also required 100 μg of neosynephrine. Two of the latter patients received CPB urgently because of sustained hypotension. The reductions in HR and MAP were highly significant statistically (P = 0.0001 and P = 0.0004, respectively). They correlated positively with each other and negatively with the change in potassium level, which increased significantly (P = 0.0001, Table 1).Table 1: Case-Control ComparisonComparison of the cases and controls (Table 1) showed that the cases were distinguished from the control group primarily by a much larger increase in serum K+ after IV heparin administration (1.94 vs 0.50 mmol/L). The final serum Na+ was significantly lower among cases than controls (134.5 vs 137.3 mmol/L). Beta-blockade was used significantly more often among controls (P = 0.04, Table 1), and type I diabetes tended to be more common among cases (P = 0.08, Table 1). Other factors potentially affecting serum K+, such as use of angiotensin-converting-enzyme inhibitors, heparin infusion, presence of renal insufficiency, and ejection fraction, were not significantly different between groups (Table 1). Discussion The principal findings of this report are that CVI occurred shortly after IV heparin administration for CPB in 16 out of 256 patients (6.25%) and that serum K+ increased by 1.94 mmol/L in patients with CVI, while serum K+ increased by a mean of 0.50 mmol/L in control patients without CVI. CVI was arbitrarily defined as MAP < 60 mm Hg and/or HR < 40 bpm. MAP and HR may have been reduced in other patients, but to a lesser degree; however, this could not be determined accurately from the available data. Further description of the hemodynamic changes associated with bolus IV heparin administration for CPB would be appropriate for prospective evaluation and is in progress. In the treated patients, hypotension, bradycardia, and the increase in K+ were closely associated. However, the classic electrocardiographic signs of hyperkalemia were not seen in any of the treated patients. The cases and controls could not be differentiated on the basis of arterial PCO2 or pH (Table 1) (7). The mean serum Na+ decreased in patients with CVI, suggesting that slight volume expansion actually occurred. It is unlikely that the observed increase in serum K+ was caused by a ventilation or volume change. Chronic administration of heparin (for days), has been associated with an increase of serum K+ of about 0.5 mmol/L (1–4). Acute administration of heparin in vitro has caused slight elevations of serum K+ (8), but IV heparin administration has not been noted to affect serum K+ acutely in humans. None of the usual medications or disease processes implicated in increasing serum K+ were found to be significant in this study. Indeed, a trend to an attenuated rise in serum K+ in patients on beta-blockers was identified. In summary, acute IV heparin (400 IU/kg) administration was closely associated with CVI in 16 of 256 patients (6.25%) undergoing CPB. A strong association between CVI and an increase in serum K+ was identified in the treated cases. Mean serum K+ rose modestly in control patients without CVI, by 0.5 mmol/L, but it increased by 1.94 mmol/L in treated cases. The mechanism of this increase in serum K+ after acute IV heparin administration is unknown, and further investigation is warranted.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,000
score de la tête « metaresearch » (Gemma)0,000
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesMéta-épidémiologie (sens strict)
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Autre devis · Signal consensuel: aucune
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,882
Score d'incertitude au seuil1,000

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0000,000
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0010,001
Bibliométrie0,0000,000
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,000
Charge utile insuffisante (le modèle a refusé de juger)0,0000,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,011
Tête enseignante GPT0,234
Écart entre enseignants0,223 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle